Vimarsana
Biggest News Aggregation in the World

Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Immunotherapy Today - Breaking & Trending Today

NK cells' role in cancer therapy resistance unveiled - Vimarsana News

NK cells' role in cancer therapy resistance unveiled

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system.

Merck and Bristol-Myers Squibb brace for loss of lucrative drug patents - Vimarsana News

Merck and Bristol-Myers Squibb brace for loss of lucrative drug patents

New quarterly earnings reports offer insight into how the companies are preparing to potentially lose significant sources of revenue

Source: qz.com
Siblings with unique gene mutation offer insights into type 1 diabetes treatment - Vimarsana News

Siblings with unique gene mutation offer insights into type 1 diabetes treatment

Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.

New immunotherapy target activin receptor 1C shows promise against cancer - Vimarsana News

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Aging alters fibroblasts to promote pancreatic cancer growth - Vimarsana News

Aging alters fibroblasts to promote pancreatic cancer growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, according to research led by investigators from the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Bloomberg School of Public Health and the Bloomberg~Kimmel Institute for Cancer Immunotherapy.